The association between miR-200a/KEAP1/NRF2 axis and tumorigenic potential was proven by in vivo experiments, showing that NFR2 pathway is turned off during tumor regression of HCC nodules. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.